policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
Editing Animals
Recent gene-editing technologies are being used to create mice that model human genetic diseases, Holstein cattle lacking horns, and current research…
JAVMA news
Iowa State confers Stange, Switzer awards
Four alumni of the Iowa State University College of Veterinary Medicine were honored Oct. 29, 2016.
JAVMA news
Iowa State confers Stange, Switzer awards
Iowa State University College of Veterinary Medicine honored four veterinarians Oct. 30, 2017.
JAVMA news
Veterinarians could lead sustainability efforts
Despite the veterinary community championing the one-health concept—that human, animal, and environmental health are intertwined—the environmental…
JAVMA news
Candidate vaccine protects pigs against African swine fever strains
A U.S. Department of Agriculture–developed vaccine against African swine fever protected pigs in a second study, suggesting progress toward a…
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.